Referenser

  1. Sun ER, Chen CA, Ho G, Earley CJ, Allen RP. Iron and the restless legs syndrome. Sleep. 1998;21(4):371-7.

  2. Kryger MH, Otake K, Foerster J. Low body stores of iron and restless legs syndrome: a correctable cause of insomnia in adolescents and teenagers. Sleep Med. 2002;3(2):127-32.

  3. Lieske B, Becker I, Schulz RJ, Polidori MC, Kassubek J, Roehrig G. Intravenous iron administration in restless legs syndrome : An observational study in geriatric patients. Z Gerontol Geriatr. 2016;49(7):626-31. Intravenose Eisengabe bei Restless-legs-Syndrom : Eine Beobachtungsstudie bei geriatrischen Patienten.

  4. Wang J, O'Reilly B, Venkataraman R, Mysliwiec V, Mysliwiec A. Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: A randomized, double-blind, placebo-controlled study. Sleep Med. 2009;10(9):973-5.

  5. Favrat B, Balck K, Breymann C, Hedenus M, Keller T, Mezzacasa A, et al. Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women--PREFER a randomized, placebo-controlled study. PLoS One. 2014;9(4):e94217.

  6. Herfs R, Fleitmann L, Kocsis I. Treatment of Iron Deficiency with or without Anaemia with Intravenous Ferric Carboxymaltose in Gynaecological Practices - A Non-Interventional Study. Geburtshilfe Frauenheilkd. 2014;74(1):81-8.

  7. Krayenbuehl PA, Battegay E, Breymann C, Furrer J, Schulthess G. Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood. 2011;118(12):3222-7.

  8. Verdon F, Burnand B, Stubi CL, Bonard C, Graff M, Michaud A, et al. Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. BMJ. 2003;326(7399):1124.

  9. Birgegard G, Schneider K, Ulfberg J. High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron. Vox Sang. 2010;99(4):354-61.

  10. Haas JD, Brownlie Tt. Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr. 2001;131(2S-2):676S-88S; discussion 88S-90S.

  11. Comin-Colet J, Enjuanes C, Gonzalez G, Torrens A, Cladellas M, Merono O, et al. Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status. Eur J Heart Fail. 2013;15(10):1164-72.

  12. Silverberg DS, Iaina A, Schwartz D, Wexler D. Intravenous iron in heart failure: beyond targeting anemia. Curr Heart Fail Rep. 2011;8(1):14-21.

  13. Herrmann M, Peter Schmidt J, Umanskaya N, Wagner A, Taban-Shomal O, Widmann T, et al. The role of hyperhomocysteinemia as well as folate, vitamin B(6) and B(12) deficiencies in osteoporosis: a systematic review. Clin Chem Lab Med. 2007;45(12):1621-32.

  14. Bickley LS SP. Bates guide to physical examination and history-taking with access code. 11th ed ed: Philadelphia: Lippincott Williams & Wilkins; 2012. ; 2012.

  15. McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr. 2009;12(4):444-54.

  16. Söderman L. Nya matvanor kan ytterligare öka prevalensen av järnbrist. Läkartidningen. 2023;120:23002.

  17. Munro MG, Mast AE, Powers JM, Kouides PA, O'Brien SH, Richards T, et al. The relationship between heavy menstrual bleeding, iron deficiency, and iron deficiency anemia. Am J Obstet Gynecol. 2023;229(1):1-9.

  18. Smith C, Teng F, Branch E, Chu S, Joseph KS. Maternal and Perinatal Morbidity and Mortality Associated With Anemia in Pregnancy. Obstet Gynecol. 2019;134(6):1234-44.

  19. DSOG (Dansk Selskab for Obstetrik og Gynækologi). Anaemia and iron deficiency in pregnancy and postpartum. 2016 [cited 2025-10-08]. Available from: http://www.nfog.org/files/guidelines/NFOG_guidelines_DEN_Anaemia%20in%20pregnancy%20and%20post%20partum_2016.pdf

  20. Breymann C, Milman N, Mezzacasa A, Bernard R, Dudenhausen J, investigators F-A. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP). J Perinat Med. 2017;45(4):443-53.

  21. Breymann C, Honegger C, Holzgreve W, Surbek D. Diagnosis and treatment of iron-deficiency anaemia during pregnancy and postpartum. Arch Gynecol Obstet. 2010;282(5):577-80.

  22. Ortiz R, Toblli JE, Romero JD, Monterrosa B, Frer C, Macagno E, et al. Efficacy and safety of oral iron(III) polymaltose complex versus ferrous sulfate in pregnant women with iron-deficiency anemia: a multicenter, randomized, controlled study. J Matern Fetal Neonatal Med. 2011;24(11):1347-52.

  23. Bhandal N, Russell R. Intravenous versus oral iron therapy for postpartum anaemia. BJOG. 2006;113(11):1248-52.

  24. Seid MH, Derman RJ, Baker JB, Banach W, Goldberg C, Rogers R. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. Am J Obstet Gynecol. 2008;199(4):435 e1-7.

  25. Van Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstet Gynecol. 2007;110(2 Pt 1):267-78.

  26. Eckerdal P, Kollia N, Lofblad J, Hellgren C, Karlsson L, Hogberg U, et al. Delineating the Association between Heavy Postpartum Haemorrhage and Postpartum Depression. PLoS One. 2016;11(1):e0144274.

  27. Sheikh M, Hantoushzadeh S, Shariat M, Farahani Z, Ebrahiminasab O. The efficacy of early iron supplementation on postpartum depression, a randomized double-blind placebo-controlled trial. Eur J Nutr. 2017;56(2):901-8.

  28. Veijola LI, Oksanen AM, Sipponen PI, Rautelin HI. Association of autoimmune type atrophic corpus gastritis with Helicobacter pylori infection. World J Gastroenterol. 2010;16(1):83-8.

  29. Zauli D, Tosti A, Biasco G, Miserocchi F, Patrizi A, Azzaroni D, et al. Prevalence of autoimmune atrophic gastritis in vitiligo. Digestion. 1986;34(3):169-72.

  30. Yin Y, Liang H, Wei N, Zheng Z. Prevalence of chronic atrophic gastritis worldwide from 2010 to 2020: an updated systematic review and meta-analysis. Ann Palliat Med. 2022;11(12):3697-703.

  31. Hershko C, Ronson A, Souroujon M, Maschler I, Heyd J, Patz J. Variable hematologic presentation of autoimmune gastritis: age-related progression from iron deficiency to cobalamin depletion. Blood. 2006;107(4):1673-9.

  32. Thrift AP, Wenker TN, El-Serag HB. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol. 2023;20(5):338-49.

  33. Duport N, Preziosi P, Boutron-Ruault MC, Bertrais S, Galan P, Favier A, et al. Consequences of iron depletion on health in menstruating women. Eur J Clin Nutr. 2003;57(9):1169-75.

  34. Auerbach M, Ballard H. Clinical use of intravenous iron: administration, efficacy, and safety. Hematology Am Soc Hematol Educ Program. 2010;2010:338-47.

  35. Goodnough LT, Nemeth E, Ganz T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood. 2010;116(23):4754-61.

  36. Aapro M, Osterborg A, Gascon P, Ludwig H, Beguin Y. Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron. Ann Oncol. 2012;23(8):1954-62.

  37. Beutler E, Hoffbrand AV, Cook JD. Iron deficiency and overload. Hematology Am Soc Hematol Educ Program. 2003:40-61.

  38. Livsmedelsverket. Vitamin B12.  [cited 2025-10-08]. Available from: https://www.livsmedelsverket.se/livsmedel-och-innehall/naringsamne/vitaminer-och-antioxidanter/vitamin-b12

  39. Hannibal L, Lysne V, Bjorke-Monsen AL, Behringer S, Grunert SC, Spiekerkoetter U, et al. Biomarkers and Algorithms for the Diagnosis of Vitamin B12 Deficiency. Front Mol Biosci. 2016;3:27.

  40. Västra Götalandsregionen. Regional medicinsk riktlinje – läkemedel. Vitamin B12- och/eller folatbrist hos vuxna. 2025 [cited 2025-10-08]. Available from: https://mellanarkiv-offentlig.vgregion.se/alfresco/s/archive/stream/public/v1/source/available/sofia/ssn11800-2140136717-726/native/Vitaminbrist%20B12%20och%20eller%20folatbrist%20hos%20vuxna.pdf

  41. Savage DG, Lindenbaum J. Neurological complications of acquired cobalamin deficiency: clinical aspects. Baillieres Clin Haematol. 1995;8(3):657-78.

  42. Nordmark Grass J, Westerbergh J, Lindeman E. Återkommande exponering för lustgas kan ge svåra skador. Läkartidningen. 2022;119:21157.

  43. Sipponen P. Prevalence rates of heathy stomach mucosa, chronic non-atrophic and atrophic gastritis in endoscopic biopsies in adults born in Finland in 1890-1977. Scand J Gastroenterol. 2021;56(8):874-81.

  44. Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med. 2004;350(20):2068-79.

  45. Hippe E, Jensen KB. Hereditary factors in pernicious anaemia and their relation to serum-immunoglobulin levels and age at diagnosis. Lancet. 1969;2(7623):721-2.

  46. Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, et al. Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018;16(6):823-36 e2.

  47. Svensk förening för Pediatrisk gastroenterologi, hepatologi och nutrition; Svenska barnläkarföreningen; Svensk förening för allmän medicin. Nationellt vårdprogram för celiaki. Version 1.0. 2020 [updated 2023-09-07; cited 2025-10-08]. Available from: https://gastro.barnlakarforeningen.se/wp-content/uploads/sites/10/2023/09/Celiaki-genomganget-20230907.pdf

  48. Martin-Masot R, Herrador-Lopez M, Navas-Lopez VM, Carmona FD, Nestares T, Bossini-Castillo L. Celiac Disease Is a Risk Factor for Mature T and NK Cell Lymphoma: A Mendelian Randomization Study. Int J Mol Sci. 2023;24(8).

  49. Kingma SDK, Neven J, Bael A, Meuwissen MEC, van den Akker M. Imerslund-Grasbeck syndrome: a comprehensive review of reported cases. Orphanet J Rare Dis. 2023;18(1):291.

  50. Jung SB, Nagaraja V, Kapur A, Eslick GD. Association between vitamin B12 deficiency and long-term use of acid-lowering agents: a systematic review and meta-analysis. Intern Med J. 2015;45(4):409-16.

  51. Pratama S, Lauren BC, Wisnu W. The efficacy of vitamin B(12) supplementation for treating vitamin B(12) deficiency and peripheral neuropathy in metformin-treated type 2 diabetes mellitus patients: A systematic review. Diabetes Metab Syndr. 2022;16(10):102634.

  52. Garakani A, Jaffe RJ, Savla D, Welch AK, Protin CA, Bryson EO, et al. Neurologic, psychiatric, and other medical manifestations of nitrous oxide abuse: A systematic review of the case literature. Am J Addict. 2016;25(5):358-69.

  53. Lettström C, Tournavitis A, Eriksson L. Lustgas i stora mängder kan ge psykiska och neurologiska symtom. Läkartidningen. 2023;120:22146.

  54. Siddiqui A, Gautam G, Agren A, Nordmark Grass J. Livshotande trombotisering efter missbruk av stor mängd lustgas. Läkartidningen. 2023;120:22151.

  55. Svensson S, Johnsson M. Allvarliga och mångfasetterade följder av användning av lustgas. Läkartidningen. 2023;120:23116.

  56. Lag om lustgas. SFS 2025:621. Svensk författningssamling; 2025 [cited 2025-10-08]. Available from: https://svenskforfattningssamling.se/sites/default/files/sfs/2025-06/SFS2025-621.pdf

  57. Lindstedt G. Lustgas kan utlösa kobalaminbrist. Vitamin B12 enkelt och billigt motmedel. Läkartidningen. 1999;96(44):4801-5.

  58. Crider KS, Zhu JH, Hao L, Yang QH, Yang TP, Gindler J, et al. MTHFR 677C->T genotype is associated with folate and homocysteine concentrations in a large, population-based, double-blind trial of folic acid supplementation. Am J Clin Nutr. 2011;93(6):1365-72.

  59. Berlin H, Berlin R, Brante G. Oral treatment of pernicious anemia with high doses of vitamin B12 without intrinsic factor. Acta Med Scand. 1968;184(4):247-58.

  60. Castelli MC, Friedman K, Sherry J, Brazzillo K, Genoble L, Bhargava P, et al. Comparing the efficacy and tolerability of a new daily oral vitamin B12 formulation and intermittent intramuscular vitamin B12 in normalizing low cobalamin levels: a randomized, open-label, parallel-group study. Clin Ther. 2011;33(3):358-71 e2.

  61. Israels MC, Wilkinson JF. Risk of neurological complications in pernicious anaemia treated with folic acid. Br Med J. 1949;2(4636):1072-5.

  62. Livsmedelsverket. Folat/folsyra före och under graviditet. 2020 [cited 2025-10-10]. Available from:  https://www.livsmedelsverket.se/globalassets/publikationsdatabas/rapporter/2020/l-2020-nr-09-folatfolsyra-fore-och-under-graviditet.pdf

  63. Leja M. Potential of personalised approaches in gastric cancer prevention. Gut. 2023;Nov 24;72(12):2225-6.

  64. Nationellt vårdprogram. Matstrups- och magsäckscancer. Regionala cancercentrum i samverkan; 2025 [cited 2025-10-10]. Available from: https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/

  65. Demir N, Koc A, Ustyol L, Peker E, Abuhandan M. Clinical and neurological findings of severe vitamin B12 deficiency in infancy and importance of early diagnosis and treatment. J Paediatr Child Health. 2013;49(10):820-4.

  66. Cruz-Rodriguez J, Canals-Sans J, Hernandez-Martinez C, Voltas-Moreso N, Arija V. Prenatal vitamin B12 status and cognitive functioning in children at 4 years of age: The ECLIPSES Study. Matern Child Nutr. 2024;20(1):e13580.

  67. Rojas-Gomez A, Sole-Navais P, Cavalle-Busquets P, Ornosa-Martin G, Grifoll C, Ramos-Rodriguez C, et al. Pregnancy homocysteine and cobalamin status predict childhood metabolic health in the offspring. Pediatr Res. 2023;Feb;93(3):633-42.

  68. Gomes S, Lopes C, Pinto E. Folate and folic acid in the periconceptional period: recommendations from official health organizations in thirty-six countries worldwide and WHO. Public Health Nutr. 2016;19(1):176-89.

  69. Iwama H, Iwase O, Hayashi S, Nakano M, Toyama K. [Macrocytic anemia with anisocytosis due to alcohol abuse and vitamin B6 deficiency]. Rinsho Ketsueki. 1998;39(11):1127-30.

  70. Suzuki M, Nakagawa M, Shimizu Y, Suemura M, Sato B. [Therapy-resistant microcytic hypochromic anemia from malabsorption-related vitamin B6 deficiency after a gastrointestinal operation]. Rinsho Ketsueki. 2005;46(9):1044-8.

  71. Hisano M, Suzuki R, Sago H, Murashima A, Yamaguchi K. Vitamin B6 deficiency and anemia in pregnancy. Eur J Clin Nutr. 2010;64(2):221-3.

  72. Scully M, Hunt BJ, Benjamin S, Liesner R, Rose P, Peyvandi F, et al. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol. 2012;158(3):323-35.

  73. Birgens H, Frederiksen H, Hasselbalch HC, Rasmussen IH, Nielsen OJ, Kjeldsen L, et al. A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia. Br J Haematol. 2013;163(3):393-9.

  74. Gartner A, Dombrowski N, Lowe N, Behzadpour V, Zackula R. Foot-strike Hemolysis: A Scoping Review of Long-Distance Runners. Kans J Med. 2024;17(5):119-24.

  75. Vasudev M, Bresnahan BA, Cohen EP, Hari PN, Hariharan S, Vasudev BS. Percussion hemoglobinuria - a novel term for hand trauma-induced mechanical hemolysis: a case report. J Med Case Rep. 2011;5:508.

  76. Nordic MDS Group.  [cited 2025-10-13]. Available from: https://www.nmds.org/

  77. Nilsson-Ehle H, Birgegard G, Samuelsson J, Antunovic P, Astermark J, Garelius H, et al. Quality of life, physical function and MRI T2* in elderly low-risk MDS patients treated to a haemoglobin level of >/=120 g/L with darbepoetin alfa +/- filgrastim or erythrocyte transfusions. Eur J Haematol. 2011;87(3):244-52.

  78. Nationellt vårdprogram. Myeloproliferativ neoplasi, MPN. Regionala cancercentrum i samverkan; 2025 [cited 2025-10-13]. Available from: https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/.

  79. Berglund S, Domellöf M. På Uppdrag av Svenska Barnläkarföreningen och Svensk förening för Neonatologi. Nationella riktlinjer: Järntillskott till prematurfödda barn och barn med låg födelsevikt. 2013 [cited 2025-10-13]. Available from: https://neo.barnlakarforeningen.se/wp-content/uploads/sites/14/2014/03/Jarntillskott_2013.pdf

  80. Vårdplaneringsgruppen för pediatrisk hematologi (VPH). Thalassemi hos barn och ungdomar. Riktlinjer för utredning, diagnostik och handläggning. 2024 [cited 2025-10-13]. Available from: https://pho.barnlakarforeningen.se/wp-content/uploads/sites/20/2024/11/PM-VPH-Thalassemi-2024.pdf

  81. Vårdplaneringsgruppen för pediatrisk hematologi. Riktlinjer Sicklecellsjukdom. 2022 [cited 2025-10-13]. Available from: https://pho.barnlakarforeningen.se/wp-content/uploads/sites/20/2023/01/PM-VPH-SCD-2022.pdf

  82. Vårdplaneringsgruppen för Pediatrisk Hematologi (VPH). Autoimmun hemolytisk anemi. VPHs riktlinjer vid AIHA hos barn. 2021 [cited 2025-10-13]. Available from: https://pho.barnlakarforeningen.se/wp-content/uploads/sites/20/2021/05/PM-AIHA-Mars-2021.pdf

Föregående sida
För vidare läsning

Nästa sida
Tillbaka till kapitlets första sida